Shunji Hasumi

Title: Shunji Hasumi: Innovator in Pharmaceutical Compositions

Introduction

Shunji Hasumi is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for medical applications. With a total of 5 patents to his name, Hasumi's work has the potential to impact the way certain medications are administered and absorbed by the body.

Latest Patents

Among his latest patents, Hasumi has developed a quick-dissolution solid preparation. This invention includes pharmaceutical compositions comprising calcitonin, which is crucial for various therapeutic applications. Additionally, he has created formulations for intranasal administration that combine calcitonin with absorption enhancers such as benzyl alcohol, ethanol, thiamine, salicylic acid, capric acid, Macrogol 400, pyridoxal, malic acid, and pyrophosphoric acid. These compositions are designed to be suitable for application to the nasal mucosa, enhancing the effectiveness of the medication.

Career Highlights

Shunji Hasumi is currently associated with Yamanouchi Pharmaceutical Company Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug delivery systems and enhancing the efficacy of treatments through advanced formulations.

Collaborations

Hasumi has collaborated with esteemed colleagues in his field, including Masayoshi Aruga and Tadayoshi Ohmura. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Shunji Hasumi's contributions to pharmaceutical compositions demonstrate his commitment to innovation in medicine. His patents reflect a deep understanding of drug formulation and delivery, which could lead to improved therapeutic outcomes for patients.